Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | Yttrium Y 90-DOTA-biotin |
| Synonyms | |
| Therapy Description |
Yttrium Y 90-DOTA-biotin is a radioconjugate comprising the radionuclide Yttrium-90 linked to the chelating agent DOTA and biotin, which may deliver targeted radiation to tumors in combination with streptavidin-conjugated antibodies, potentially resulting in reduced tumor growth (PMID: 25785845, PMID: 24371230). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| Yttrium Y 90-DOTA-biotin | 90Y-DOTA-Biotin | Yttrium Y 90-DOTA-biotin is a radioconjugate comprising the radionuclide Yttrium-90 linked to the chelating agent DOTA and biotin, which may deliver targeted radiation to tumors in combination with streptavidin-conjugated antibodies, potentially resulting in reduced tumor growth (PMID: 25785845, PMID: 24371230). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06390241 | Phase I | Yttrium Y 90-DOTA-biotin | Avidination for RadionuclideTHerapy in Nonpalpable Breast Cancer (ARTHE) | Terminated | ITA | 0 |